News
For patients with BRAF V600E-mutated metastatic CRC, overall survival significantly longer with encorafenib + cetuximab + chemotherapy.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback